AstraZeneca Pharma gets nod to sell immunotherapy drug Durvalumab; stock surges

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

Sep 24, 2024 - 08:30
 0  2
AstraZeneca Pharma gets nod to sell immunotherapy drug Durvalumab; stock surges
This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow